Turn Therapeutics, Inc. , a clinical-stage biotechnology company developing targeted, non-systemic therapies for inflammatory skin diseases, today announced the completion of a comprehensive interim ...

Access to Thrive graduated the first cohort of its S.T.E.P. (Skills Training and Entrepreneurial Pathways) program, Thursday, ...

No timeline has been finalized for a future building on the University of North Dakota campus that will bring students together in the name of serving the state's healthcare ...

Trekor Metals Limited (TSX: TKO; NYSE American: TGB; LSE: TKO) (“Trekor” or the "Company") is pleased to provide an update on ...

NetworkNewsWire Editorial Coverage: The threats confronting law enforcement, military commands and critical infrastructure operators have crossed a threshold. They can no longer ...

Teva-discovered TEV-’408 targets IL-15, a key driver of vitiligo biology TEV-’408 showed improvement in skin pigmentation and was well-tolerated with no safety signals observed to dateNearly 75% of pa ...

In a region often defined by its economic challenges, a grassroots initiative in the Imperial Valley is redefining what entrepreneurship looks like—and who gets to participate.

Co-branded credit cards are evolving beyond rewards and loyalty points. As banks and brands deepen partnerships, these cards are becoming powerful tools for building long-term customer relationships ...

SIX OF NINE HOLES RETURN ANOMALOUS RADIOACTIVITY IN EXPANDED 4,092 METRE CAMPAIGN VANCOUVER, BC / ACCESS Newswire / July 7, 2026 / UraniumX Discovery Corp. ("UraniumX" or the "Company" ...

Now a new generation of devices is trying to do something the read-only wearable never could, talk back to the body.

ISRO successfully tests SOLVE motor at Sriharikota, validating Gaganyaan parachute safety and advancing India’s human ...

Definium Therapeutics, Inc. (“Definium” or the “Company”), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics intended to address underlying causes of ...